Exhibit Hall

Product Demo Videos
CORPORATE SPONSOR:

Regeneron Pharmaceuticals

Our mission has been to use the power of science to bring new medicines to patients. We use our homegrown technologies to discover, develop, research and deliver new medicines that help people with serious diseases.

Contact:

Medical Information

(855) 734-3648

MEETING SUPPORTERS:

Dompé is an Italian biopharmaceutical company based in Milan with US headquarters in the San Francisco Bay area. Dompé’s commitment to ophthalmology includes the first topical biologic FDA-approved for an ophthalmic indication.

Contact:

Mark Fisher

Key Account Manager

(513) 312-2374

Allergan, an AbbVie company (NYSE: ABBV), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

Contact:

Ralph Robinson

Sr. Specialty Representative - Eye Care

(614) 339-9052

Novartis.jpg
EXHIBITORS:
OMIC logo web.jpg

OMIC is the largest insurer of ophthalmologists in the United States, and the only insurance carrier dedicated specifically to ophthalmology. OMIC offers competitive rates, premium discounts and dividends.

Contact:

Joe DiBernardo

Regional Marketing & Sales Manager

(415) 423-7039

AdvancedMD web.jpg

AdvancedMD offers an integrated suite of cloud solutions including practice management, patient scheduling, billing services, business reporting and analytical reporting, and is uniquely integrated with top Ophthalmology EMR vendors. 

Contact:

Zach Curtis

District Manager 

(801) 988-7195

Eversight web.jpg

Eversight is a nonprofit global eye bank network with a mission to restore sight and prevent blindness through the healing power of eye donation, corneal transplantation and vision research.

Contact:

Mary McMurray

Partner Relations & Philanthropy Director

(216) 706-4217

Ivantis, Inc.

Ivantis-web.jpg

MORE THAN A STENT,
A SYSTEM.
 The Hydrus Microstent from Ivantis, Inc is a revolutionary canal-based minimally invasive glaucoma surgery (MIGS) device for patients with mild to moderate primary open-angled glaucoma.

Contact:

Terry Henschen

Glaucoma Surgical Representative

(330) 323-5875

Sanofi.png

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

Contact:

Ben Talbot

Area Business Leader

(740) 704-5121

Creating a world connected by Sight. J&J Vision brings together cutting-edge insights, science, technology and people to encourage professionals and patients to proactively preserve and enhance sight for life.

Contact:

Bill Brunke

Account Executive

(740) 739-7584

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology.

Contact:

Ryan Stitsinger

Key Account Manager

(937) 542-0784

Alcon, the global leader in eye care, offers the broadest portfolio of Surgical and Vision Care products to enhance sight and improve lives.

Visit www.alcon.com.

Contact:

John Flood

Sr. Surgical Consultant

(214) 507-5857

Glaukos, corporate founder of micro-invasive glaucoma surgery (MIGS), is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma corneal disorders and retinal diseases.

Contact:

Cody McKenzie

Senior Director Global Marketing

(949) 481-0216

Aerie.jpg

Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. Visit us at www.aeriepharma.com

Contact:

Kate Currutt

District Manager

(435) 640-9113

We are IT Professionals across four regional offices that are fully committed to keeping your Practice Technology running so you can provide the best possible care to your patient.

Contact:

Wes Strickling

CEO

(614) 486-9900

GENE_LOCKUP_Primary_FullColor_RGB.png

For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.

Contact:

Kurt Newman

Therapeutic Area Manager

(330) 606-8135